The U.S. protein expression market is expected to grow at a CAGR of 11.6% during the forecast period with its market size predicted to reach USD 1.2 billion by 2024. The U.S. protein expression market is primarily driven by the factors such as the increasing prevalence of chronic diseases, increasing investment for recombinant protein expression, advancement in technology for expression systems, increasing geriatric population, and robust growth of the life sciences industry in the country. Prokaryotic expression systems and mammalian cell expression systems are the major contributors to the protein expression industry in the region.

Read More: https://www.vynzresearch.com/healthcare/us-protein-expression-market

Based on application, the market is categorized into therapeutics, research, and industries. The increasing number of chronic diseases on a global level led to the application of protein expression majorly in finding therapy for chronic diseases. Also, the increasing number of life science and biopharmaceutical industries also adds to the largest contribution of therapeutics category to the protein expression market. Other key applications include research purposes and commercial productions of proteins in industries.

The increasing prevalence of chronic diseases, increasing funding for recombinant protein expression from government and non-government organizations, advancement in technology for expression systems, increasing geriatric population, and robust growth of the life sciences industry in the country are the primary growth drivers for the U.S. protein expression industry. Different government and non-government organizations are funding investment for the development of protein biologics. Technological advancements such as microfluidics have advanced the approach of protein expression system such as a cell-free expression system. Cell-free expression systems provide a very high yield of proteins are being proved efficient for the development of protein biologics.

The high cost of reagents and equipment, complexities associated with purification of proteins are the key challenges faced by the U.S. protein expression industry.

Download Free Report Sample At: https://www.vynzresearch.com/healthcare/us-protein-expression-market/request-sample

Some of the key players operating in the U.S. protein expression market are New England Biolabs, Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., Takara Bio Inc., Lonza Group Ltd., Merck KGaA, Promega Corporation, Genscript Biotech Corporation, Agilent Technologies Inc., and Bio-Rad Laboratories, Inc.

About VynZ Research
VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies.

Contact

Manager: Client Care

Toll-Free: 18882533960

Email: [email protected]

Website: www.vynzresearch.com